InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: friendofthedevil post# 3940

Wednesday, 05/13/2015 6:54:47 PM

Wednesday, May 13, 2015 6:54:47 PM

Post# of 8493
Session Type: Oral Abstract Session
Track(s): Gastrointestinal (Noncolorectal) Cancer
Presentation(s):



Abstract #4006

10:00 AM - 10:12 AM

High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized phase II study.

Sunil R. Hingorani, MD, PhD

Fred Hutchinson Cancer Research Center"

OK, I am confused. Where are you seeing data or any mention of OS being presented?

All I can find is repeating the PR and the PFS/ORR abstract will be presented orally at meeting.

Did I miss a link somewhere?

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News